Cargando…

Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

BACKGROUND: Heterogeneity of liver function and tumor burden in intermediate-stage hepatocellular carcinoma (HCC) results in different outcomes after transarterial chemoembolization (TACE). Easy albumin-bilirubin (EZ-ALBI), a simplified albumin-bilirubin (ALBI) score, has recently been proposed as a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ananchuensook, Prooksa, Sriphoosanaphan, Supachaya, Suksawatamnauy, Sirinporn, Siripon, Nipaporn, Pinjaroen, Nutcha, Geratikornsupuk, Nopavut, Kerr, Stephen J., Thanapirom, Kessarin, Komolmit, Piyawat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199248/ https://www.ncbi.nlm.nih.gov/pubmed/35701739 http://dx.doi.org/10.1186/s12876-022-02366-y

Ejemplares similares

The association between vitamin D receptor polymorphism and phases of chronic hepatitis B infection in HBV carriers in Thailand
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Stability of hepatitis B virus pregenomic RNA in plasma specimens under various temperatures and storage conditions
por: Rattanachaisit, Pakkapon, et al.
Publicado: (2021)

Tu1269: IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Immunogenicity and safety of heterologous versus homologous prime-boost regimens with adenoviral vectored and mRNA SARS-CoV-2 vaccine in liver transplant recipients: a prospective study
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Durability of SARS-CoV-2 specific immune response following different primary prime-boost vaccine platforms and subsequent humoral response to booster dose among liver transplant recipients
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2022)

Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Hepatic Necrosis Mimicking Infiltrative Masses in Acute Budd-Chiari Syndrome With Hereditary Protein C Deficiency
por: Ananchuensook, Prooksa, et al.
Publicado: (2022)

Clinical significance of post-liver transplant hepatitis E seropositivity in high prevalence area of hepatitis E genotype 3: a prospective study
por: Komolmit, Piyawat, et al.
Publicado: (2020)

Predictive Role of Pretreatment Circulating miR-221 in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Pinjaroen, Nutcha, et al.
Publicado: (2023)

Psychometric Hepatic Encephalopathy Score for the Diagnosis of Minimal Hepatic Encephalopathy in Thai Cirrhotic Patients
por: Thanapirom, Kessarin, et al.
Publicado: (2023)

Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2020)

Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2021)

Association between Vitamin D Receptor Single-Nucleotide Polymorphisms and Colorectal Cancer in the Thai Population: A Case-Control Study
por: Suksawatamnuay, Sirinporn, et al.
Publicado: (2020)

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection
por: Thanapirom, Kessarin, et al.
Publicado: (2022)

Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial
por: Komolmit, Piyawat, et al.
Publicado: (2017)

Atypical Image of Hepatocellular Carcinoma Mimicking Hemangioma
por: Aumpansub, Prapimphan, et al.
Publicado: (2016)

Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study
por: Komolmit, Piyawat, et al.
Publicado: (2017)

Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030
por: Sintusek, Palittiya, et al.
Publicado: (2022)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection
por: Thanapirom, Kessarin, et al.
Publicado: (2015)

Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients
por: Thanapirom, Kessarin, et al.
Publicado: (2017)

Autoimmune Hepatitis Triggered by COVID-19 Vaccine: The First Case From Inactivated Vaccine
por: Mekritthikrai, Krittaya, et al.
Publicado: (2022)

Calcitriol Protects against Acetaminophen-Induced Hepatotoxicity in Mice
por: Sriphoosanaphan, Supachaya, et al.
Publicado: (2023)

Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma
por: Kunadirek, Pattapon, et al.
Publicado: (2021)

Targeted Proteins Reveal Cathepsin D as a Novel Biomarker in Differentiating Hepatocellular Carcinoma from Cirrhosis and Other Liver Cancers
por: Chuaypen, Natthaya, et al.
Publicado: (2022)

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

Hepatopleural Fistula with Empyema Thoracis: A Rare Complication of Autosomal Dominant Polycystic Kidney Disease
por: Maytapa, Jeerawat, et al.
Publicado: (2018)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

The incidence, etiologies, outcomes, and predictors of mortality of acute liver failure in Thailand: a population-base study
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

A comprehensive discharge planning program on fatigue and functional status of patients with hepatocellular carcinoma undergoing transarterial chemoembolization: A randomized clinical controlled trial
por: Yenjai, Nawiya, et al.
Publicado: (2022)

Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography
por: Teeratorn, Nicha, et al.
Publicado: (2019)

Genetic screening to avoid adverse drug reactions from medication use and approach patients' better outcomes: A lesson learn from the report of the Queen Savang Vadhana Memorial Hospital
por: Tunwongsa, Kessada, et al.
Publicado: (2022)

Modified albumin-bilirubin predicted survival of unresectable hepatocellular carcinoma patients treated with immunotherapy
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study
por: Thanapirom, Kessarin, et al.
Publicado: (2017)

Vitamin D-Binding protein Gene Polymorphism Predicts Pegylated Interferon-Related HBsAg Seroclearance in HBeAg-Negative Thai Chronic Hepatitis B Patients: A Multicentre Study
por: Thanapirom, Kessarin, et al.
Publicado: (2019)

In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944-

Effect of Transarterial Chemoembolization on ALBI Grade in Intermediate-Stage Hepatocellular Carcinoma: Criteria for Unsuitable Cases Selection
por: Chi, Chen-Ta, et al.
Publicado: (2021)

To determine the prognostic value of the albumin–bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma
por: Khalid, Muhammad Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1mg7m3p0asmkg68jnpik6busu2